Clinical Trial Update: A Study of Venetoclax and Rituximab/Hyaluronidase Human in Relapsed/Refractory CLL [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating venetoclax in combination with rituximab and hyaluronidase for relapsed/refractory chronic lymphocytic leukemia; the study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Rituxan Hycela (rituximab/hyaluronidase)
• Venclexta (venetoclax)

Snippet

Sponsor: Georgetown University | Conditions: Chronic Lymphocytic Leukemia | Phase 2 | Status: ACTIVE_NOT_RECRUITING